Cadrenal Therapeutics Inc (CVKD)
Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process
Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process
Profound Medical Launches ‘Lets Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress onHemopurifier® Program
A New Press Release from Elicio Therapeutics
Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Net Power Reports Second Quarter 2026 Results and Provides Business Update
Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
Lear Declares Quarterly Cash Dividend
EPR Properties Declares Monthly Dividend for Common Shareholders